Reassuringly, the pattern of p53-dependent gene expression induced by MDM2 inhibition was found to be substantially different in CLL cells compared to normal blood cells, with predominantly cell-cycle arrest rather than apoptosis being elicited in normal cells at therapeutic MDM2 inhibitor concentrations [56]. The gene discussed is MDM2; the disease is B-cell chronic lymphocytic leukemia.